Capsule Endoscopy as an Alternative to Colonoscopy (CAPSUCOVID)
Colonic Disease
About this trial
This is an interventional diagnostic trial for Colonic Disease
Eligibility Criteria
Inclusion Criteria: Iron deficiency anaemia with or without a colonoscopy performed within the last 5 years Rectal bleeding/haematochezia in patients >50 years who have undergone a colonoscopy <5 years ago or <50 years with no risk factors for CRC Chronic constipation/abdominal distension/abdominal pain/diarrhea Suspected CRC due to clinical criteria (NICE guidelines 2015, updated in 2017) with no iFOBT performed Recent change in bowel habits Follow-ups: post-polypectomy syndrome, family history of CRC, hereditary syndromes, CRC surgery, Inflammatory Bowel Disease Exclusion Criteria: Study following an episode of complicated acute diverticulitis or with an uncertain diagnosis of acute diverticulitis Evaluation following fragmented resection (recurrence ruled out) Patients with a positive FIT Pregnancy or breast-feeding Any contraindication to Crohn's Capsule endoscopy such as known or suspected gastrointestinal obstruction, strictures or fistulas, a previous altered Patency capsule, dysphagia or other swallowing disorders and cardiac pacemakers or other implanted electromedical devices. Allergy or known contraindication to the medications and preparations agents used in the procedure.
Sites / Locations
- Hospital universitario de Santa Cruz de TenerifeRecruiting
- Hospital clinic of barcelonaRecruiting
- Hospital Sant PauRecruiting
- Hospital Mutua de TerrassaRecruiting
Arms of the Study
Arm 1
Other
Pillcam Crohn's Capsule Endoscopy and colonoscopy
All patients will be submitted to a Pillcam Crohn's Capsule Endoscopy (Medtronic) previous their colonoscopy